Triple negative breast cancer: A continuing challenge.
作者信息
Gupta Sudeep
机构信息
Editor-in-Chief, Professor of Medical Oncology, Breast Cancer Working Group, Tata Memorial Hospital, Mumbai, Maharashtra, India. E-mail:
出版信息
Indian J Med Paediatr Oncol. 2013 Jan;34(1):1-2. doi: 10.4103/0971-5851.113393.
Abstract
摘要
相似文献
1
Triple negative breast cancer: A continuing challenge.三阴性乳腺癌：一项持续存在的挑战。
Indian J Med Paediatr Oncol. 2013 Jan;34(1):1-2. doi: 10.4103/0971-5851.113393.
2
Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial.帕博利珠单抗联合化疗对比安慰剂联合化疗用于治疗既往未经治疗的局部晚期不可切除或转移性三阴性乳腺癌（KEYNOTE-355）：一项随机、安慰剂对照、双盲、III 期临床研究。
Lancet. 2020 Dec 5;396(10265):1817-1828. doi: 10.1016/S0140-6736(20)32531-9.
3
The efficacy of betulinic acid in triple-negative breast cancer.桦木酸在三阴性乳腺癌中的疗效。
SAGE Open Med. 2014 Sep 29;2:2050312114551974. doi: 10.1177/2050312114551974. eCollection 2014.
4
Triple-negative breast cancer: an unmet medical need.三阴性乳腺癌：亟待满足的医学需求。
Oncologist. 2011;16 Suppl 1:1-11. doi: 10.1634/theoncologist.2011-S1-01.
5
Targeting the Nerve Growth Factor Signaling Impairs the Proliferative and Migratory Phenotype of Triple-Negative Breast Cancer Cells.靶向神经生长因子信号传导会损害三阴性乳腺癌细胞的增殖和迁移表型。
Front Cell Dev Biol. 2021 Jun 29;9:676568. doi: 10.3389/fcell.2021.676568. eCollection 2021.
6
Systems Medicine Design for Triple-Negative Breast Cancer and Non-Triple-Negative Breast Cancer Based on Systems Identification and Carcinogenic Mechanisms.基于系统辨识和致癌机制的三阴性乳腺癌与非三阴性乳腺癌的系统医学设计。
Int J Mol Sci. 2021 Mar 17;22(6):3083. doi: 10.3390/ijms22063083.
7
Triple Negative Breast Cancer in Pregnancy and Postpartum: Two Case Reports in Hispanic Women.孕期及产后三阴性乳腺癌：两例西班牙裔女性病例报告
Case Rep Obstet Gynecol. 2015;2015:856931. doi: 10.1155/2015/856931. Epub 2015 Sep 13.
8
Management of Triple-Negative Breast Cancer in Older Patients: How Is It Different?老年三阴性乳腺癌的管理：有何不同？
Oncology (Williston Park). 2018 Feb 15;32(2):58-63.
9
Triple-Negative Breast Cancer: Who Should Receive Neoadjuvant Chemotherapy?三阴性乳腺癌：谁应接受新辅助化疗？
Surg Oncol Clin N Am. 2018 Jan;27(1):141-153. doi: 10.1016/j.soc.2017.08.004.
10
Metabolic Reprogramming in Triple-Negative Breast Cancer.三阴性乳腺癌中的代谢重编程
Front Oncol. 2020 Mar 31;10:428. doi: 10.3389/fonc.2020.00428. eCollection 2020.
引用本文的文献
1
Methoxyhispolon Methyl Ether, a Hispolon Analog, Thwarts the SRC/STAT3/BCL-2 Axis to Provoke Human Triple-Negative Breast Cancer Cell Apoptosis In Vitro.甲氧基漆酚甲基醚，一种漆酚类似物，可阻断SRC/STAT3/BCL-2轴，在体外诱导人三阴性乳腺癌细胞凋亡。
Biomedicines. 2023 Oct 10;11(10):2742. doi: 10.3390/biomedicines11102742.
2
A Comparative Study of Clinical Profile and Relapse Patterns in TRIPLE-NEGATIVE and NonTriple-Negative Breast Cancer Patients Treated with Curative Intent.三阴性和非三阴性乳腺癌患者根治性治疗后的临床特征及复发模式的比较研究
Indian J Surg Oncol. 2017 Sep;8(3):291-297. doi: 10.1007/s13193-017-0634-5. Epub 2017 Feb 27.
3
Promoter Hypermethylation and Expression Changes of BRCA1 Gene in a Cohort of Sporadic Breast Cancer Cases among Pakistani Population.BRCA1 基因启动子甲基化与巴基斯坦散发性乳腺癌病例群表达变化。
Asian Pac J Cancer Prev. 2020 Aug 1;21(8):2395-2401. doi: 10.31557/APJCP.2020.21.8.2395.
4
Preparation of pentagamaboronon-0 and its fructose and sorbitol complexes as boron carrier for boron neutron capture therapy (BNCT) application.制备用于硼中子俘获疗法（BNCT）的五硼烷 -0 及其果糖和山梨醇配合物作为硼载体。
Res Pharm Sci. 2019 Aug;14(4):286-292. doi: 10.4103/1735-5362.263552.
5
Association of Genome-Wide Association Study (GWAS) Identified SNPs and Risk of Breast Cancer in an Indian Population.全基因组关联研究（GWAS）鉴定的单核苷酸多态性与印度人群乳腺癌风险的关联。
Sci Rep. 2017 Jan 18;7:40963. doi: 10.1038/srep40963.
Zotero 插件